Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$198K
Filings
60
Firms Hired
1
Active Period
2012–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
2025 · fourth_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Client expense: — · Firm income: —
Matched citations: HR 3092
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
2025 · fourth_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Physician reimbursement, HR 3092
Client expense: — · Firm income: —
Matched citations: HR 3092
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
2025 · fourth_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Physician reimbursement, HR 3092
Client expense: — · Firm income: —
Matched citations: HR 3092
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
2025 · fourth_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Client expense: — · Firm income: —
Matched citations: HR 3092
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
2025 · third_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Client expense: — · Firm income: —
Matched citations: HR 3092
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
2025 · third_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Physician reimbursement, HR 3092
Client expense: — · Firm income: —
Matched citations: HR 3092
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
2025 · second_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Client expense: — · Firm income: —
Matched citations: HR 3092
Medicare Patient Access and Practice Stabilization Act of 2025
2025 · second_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Physician reimbursement, HR 879
Client expense: — · Firm income: —
Matched citations: HR 879
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
2025 · first_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Patient Protection and Fraud Elimination Act, HR 3092, ALS Better Care Act (not yet introduced), medical research funding
Client expense: $12,000 · Firm income: —
Matched citations: HR 3092
Medicare Patient Access and Practice Stabilization Act of 2025
2025 · first_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Physician reimbursement, HR 879
Client expense: $12,000 · Firm income: —
Matched citations: HR 879
To amend title XVIII of the Social Security Act to provide for additional requirements with respect to electrodiagnostic services under the Medicare program.
2020 · fourth_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Quality electrodiagnostic medicine - HR 8780
Client expense: — · Firm income: —
Matched citations: HR 8780
To amend title XVIII of the Social Security Act to provide for additional requirements with respect to electrodiagnostic services under the Medicare program.
2020 · fourth_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Quality electrodiagnostic medicine - HR 8780
Client expense: — · Firm income: —
Matched citations: HR 8780
Patients' Access to Treatments Act of 2015
2015 · third_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Accreditation and reimbursement - creating mandatory standards for electrodiagnostic testing (needle EMG and nerve conduction studies) NIH funding of at least $32 billion for federal medical research Ensuring Access to Clinical Trials Act (S. 139/H.R. 209) - This legislation passed the Senate and needs to be passed by the House before financial incentives for patients to participate in rare disease clinical trials lapse later this year Patients Access to Treatments Act (H.R. 1600) - Some conditions diagnosed through EDX testing are progressive and treatment needs to begin as quickly as possible. Restrictive coinsurance requirements on innovative therapies create significant barriers for patients in need of life-changing therapies.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1600
Ensuring Access to Clinical Trials Act of 2015
2015 · third_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Accreditation and reimbursement - creating mandatory standards for electrodiagnostic testing (needle EMG and nerve conduction studies) NIH funding of at least $32 billion for federal medical research Ensuring Access to Clinical Trials Act (S. 139/H.R. 209) - This legislation passed the Senate and needs to be passed by the House before financial incentives for patients to participate in rare disease clinical trials lapse later this year Patients Access to Treatments Act (H.R. 1600) - Some conditions diagnosed through EDX testing are progressive and treatment needs to begin as quickly as possible. Restrictive coinsurance requirements on innovative therapies create significant barriers for patients in need of life-changing therapies.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 209
Ensuring Access to Clinical Trials Act of 2015
2015 · third_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
Electrodiagnostic Accreditation and reimbursement - creating mandatory standards for electrodiagnostic testing (needle EMG and nerve conduction studies) NIH funding of at least $32 billion for federal medical research Ensuring Access to Clinical Trials Act (S. 139/H.R. 209) - This legislation passed the Senate and needs to be passed by the House before financial incentives for patients to participate in rare disease clinical trials lapse later this year Patients Access to Treatments Act (H.R. 1600) - Some conditions diagnosed through EDX testing are progressive and treatment needs to begin as quickly as possible. Restrictive coinsurance requirements on innovative therapies create significant barriers for patients in need of life-changing therapies.
Client expense: $20,000 · Firm income: —
Matched citations: S. 139
Patients' Access to Treatments Act of 2013
2014 · third_quarter · Firm: AANEM AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE
- CMS reimbursement rate cuts for electrodiagnostic medicine in 2013 - H.R. 460 - support for patient's access to treatment to limit cost-sharing requirements applicable to medications in a specialty drug tier - Delay implementation of Sunshine Act to allow time for physicians to review. - Support permanent repeal of the Medicare Sustainable Growth Rate
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 460
Source: Senate LDA